Chemokines as new actors in the dopaminergic system;Les chimiokines, de nouveaux acteurs dans le système dopaminergique

Biologie Aujourd'hui

Volumn 204, Issue 4, 2010, Pages 295-300

  Apartis, Emmanuelle ^a,b   Mélik Parsadaniantz, Stéphane ^b   Guyon, Alice ^c   Kitabgi, Patrick ^b,d   Rostène, William ^e  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^e INSTITUT DE LA VISION   (France)

Author keywords

Chemokines; Dopamine; Neurodegeneration; Neuromodulation; Parkinson's disease

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR4; DOPAMINE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1;

ANIMAL; ARTICLE; HUMAN; NERVE CELL; NERVE DEGENERATION; PHYSIOLOGY;

ANIMALS; CHEMOKINE CCL2; CHEMOKINE CXCL12; HUMANS; NERVE DEGENERATION; NEURONS; NEUROTRANSMITTER AGENTS; RECEPTORS, CCR2; RECEPTORS, CXCR4; RECEPTORS, DOPAMINE;

EID: 78651290795     PISSN: 21050678     EISSN: 21050686     Source Type: Journal    
DOI: 10.1051/jbio/2010023     Document Type: Article

References (32)

1. Apartis E., Trocello J.M., Skrzydelski D., Mélik-Parsadaniantz S., Sorokine A., Kitabgi P., Rostène W., Changes in SDF-1/CXCR4 and MCP-1/CCR2 expression in the substantia nigra of the 6-hydroxydopaminelesioned rat. Communication à la Société des Neurosciences. Mai 2005, Lille.
2. Banisadr G., Quéraud-Lesaux F., Boutterin M.C., Pélaprat D., Zalc B., Rostène W., Haour F., Parsadaniantz S.M., Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem, 2002a, 81, 257-269.
3. Banisadr G., Fontanges P., Haour F., Kitabgi P., Rostène W., Mélik-Parsadaniantz S., Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur J Neurosci, 2002b, 16, 1661-1671.
4. Banisadr G., Skrzydelski D., Kitabgi P., Rostène W., Parsadaniantz S.M., Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur J Neurosci, 2003, 18, 1593-1560.
5. Banisadr G., Gosselin R., Mechighel P., Kitabgi P., Rostène W., Mélik-Parsadaniantz S., Highly regionalized neuronal expression of MCP-1/CCL2 in rat brain. Evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol, 2005, 489, 275-292.
6. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A., CXCR4-activated astrocyte glutamate release via TNFalpha : amplification by microglia triggers neurotoxicity. Nat Neurosci, 2001, 4, 702-710.
7. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A., The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature, 1996, 382, 829-833. (Pubitemid 26299570)
8. Brouard A., Pélaprat D., Dana C., Vial M., Lhiaubet A.M., Rostène W., Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors. Neuroscience, 1992, 12, 1409-1415.
9. Callier S., Le Saux M., Lhiaubet A.M., Di Paolo T., Rostène W., Pélaprat D., Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurons in primary culture. J Neurochem, 2002, 80, 307-316.
10. Cicchetti F., Brownell A.L., William K., Chen Y.I., Livni E., Isacson O., Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci, 2002, 15, 991-998.
11. Guyon A., Skrzydelski D., Rovère C., Rostène W., Mélik-Parsadaniantz S., Nahon J.L., Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones : presynaptic mechanisms. J Neurochem, 2006, 96, 1540-1550.
12. Guyon A., Skrzydelski D., Rovère C., Apartis E., Rostène W., Kitabgi P., Mélik-Parsadaniantz S., Nahon J.L., Stromal-cell-derived factor1alpha/CXCL12 modulates high-threshold calcium currents in rat substantia nigra. Eur J Neurosci, 2008, 28, 862-870.
13. Guyon A., Skrzydelski D., De Giry I., Rovère C., Conductier G., Trocello J.M., Daugé V., Kitabgi P., RostèneW., Nahon J.L., Mélik-Parsadaniantz S., Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience, 2009, 15, 1072-1080.
14. Hébert G., Arsaut J., Dantzer R., Demotes-Mainard J., Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4- phenyl-1, 2, 3, 6-tetrahydropyridine, a dopaminergic neurotoxin. Neurosci Lett, 2003, 349, 191-195.
15. Hirsch E.C., Glial cells and Parkinson's disease. J Neurol, 2000, 247, II/58-II/62.
16. Kaul M., Garden G.A., Lipton S.A., Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature, 2001, 410, 988-994.
17. Kurkowska-Jastrzebska I., Wronska A., Kohutnicka M., Czlonkowski A., Czlonkowska A., The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine intoxication in mouse. Exp Neurol, 1999, 156, 50-61. (Pubitemid 29152982)
18. Limatola C., Giovannelli A., Maggi L., Ragozzino D., Castellani L., Ciotti M.T., Vacca F., Mercanti D., Santoni A., Eusebi, F., SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum. Eur J Neurosci, 2000, 12, 2497-2504.
19. Lorenzl S., Albers D.S., Narr S., Chirichigno J., Beal M.F., Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease. Exp Neurol, 2002, 178, 13-20.
20. Lorenzl S., Calingasan N., Yang L., Albers D.S., Shugama S., Gregorio J., Krell H.W., Chirichigno J., Joh T., Beal M.F., Matrix metalloproteinase-9 is elevated in 1- methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonism in mice. Neuromolecular Med, 2004, 5, 119-132.
21. Meucci O., Fatatis A., Simen A.A., Miller R.J., Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci USA, 2000, 97, 8075-8080.
22. McQuibban G.A., Butler G.S., Gong G.H., Bendall L., Power C., Clark-Lewis I., Overall C.M., Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem, 2001, 276, 43503-43508.
23. Nagatsu T., Mogi M., Ichinose H., Togari A., Cytokines in Parkinson's disease. J Neural Transm Suppl., 2000, 58, 143-51.
24. Oberlin E., Amara A., Bachèlerie F., Bessia C., Virelizier J.L., Arenzana-Seisdedos F., Schwartz O., Heard J.M., Clark-Lewis I., Legler D.F., Loetscher M., Baggiolini M., Moser B., The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-lineadapted HIV-1. Nature, 1996, 382, 833-835. Erratum in: Nature 1996, 384, 288.
25. Pycock C.J., Turning behaviour in animals. Neuroscience, 1980, 5, 461-514.
26. Skrzydelski D., Guyon A., Dauge V., Rovère C., Apartis E., Kitabgi P., Nahon J.L., Rostène W., Mélik-Parsadaniantz S., The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J Neurochem, 2007, 102, 1175-1183.
27. Valenzuela-Fernandez A., Planchenault T., Baleux F., Staropoli I., Le Barillec K., Leduc D., Delaunay T., Lazarini F., Virelizier J.L., Chignard M., Pidard D., Arenzana-Seisdedos F., Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF- 1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem, 2002, 277, 15677-15689.
28. Vila M., Jackson-Lewis V., Guégan C.,Wu D.C., Teismann P., Choi D.K., Tieu K., Przedborski S., The role of glial cells in Parkinson's disease. Curr Opin Neurol, 2001, 14, 483-489.
29. Shimoji M., Pagan F., Healton E.B., Mochetti I., CXCR4 and CXCL12 expression is increased in the nigrostriatal system of Parkinson's disease. Neurotox Res, 2009, 16, 318-328.
30. Vergote D., Butler G.S., Ooms M., Cox J.H., Silva C., Hollenberg M.D., Jhamandas J.H., Overall C.M., Power C., Proteolytic processing of SDF-1a reveals a change in receptor specificity mediating HIVassociated neurodegeneration. Proc Nat Acad Sci USA, 2006, 103, 19182-19187.
31. Wightman R.M., Robinson D.L., Transient changes in mesolimbic dopamine and their association with "reward". J Neurochem, 2002, 82, 721-35.
32. Zhang K., McQuibban G.A., Silva C., Butler G.S., Johnston J.B., Holden J., Clark-Lewis I., Overall C.M., Power C., HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nature Neurosci, 2003, 6, 1064-1070.